Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medix Biochemica

Medix Biochemica?uq=PEM9b6PF
1985 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and producer of monoclonal antibodies and recombinant antigens for In Vitro Diagnostics ("IVD") sectors in Espoo, Finland. The company also offers diagnostic tests specifically designed for the women's health sector which are safe, effective and suitable for intended use.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • Klovinpellontie 3
  • 02180 Espoo
  • Finland

+358 09 000000

Medix Biochemica Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medix Biochemica‘s full profile, request access.

Request full access to PitchBook

Medix Biochemica Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Medix Biochemica‘s full profile, request access.

Request full access to PitchBook

Medix Biochemica Executive Team (2)

Name Title Board
Seat
Contact
Info
Ismo RĂ¥man Chief Executive Officer
Ilkka Kouvonen Ph.D Founder

Medix Biochemica Board Members (1)

Name Representing Role Since Contact
Info
000-000000000 0000000 Self Chairman 000 0000